Global Drug-Device Combination Products Market Growth (Status and Outlook) 2024-2030
Drug-Device Combination Products market, valued at US$34.43B in 2023, forecasted to reach US$53.42B by 2030, fueled by rising demand with 6.5% CAGR.
- Bonafide Trust
- 04-01-2024
- Pages : 160
- Figures : 79
- Tables : 158
- Region : Global
- Category : Lifescience
- Medical Devices
According to publisher, the global Drug-Device Combination Products market size was valued at US$ 34430 million in 2023. With growing demand in downstream market, the Drug-Device Combination Products is forecast to a readjusted size of US$ 53420 million by 2030 with a CAGR of 6.5% during review period.
The research report highlights the growth potential of the global Drug-Device Combination Products market. Drug-Device Combination Products are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug-Device Combination Products. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug-Device Combination Products market.
Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
Key Features:
The report on Drug-Device Combination Products market reflects various aspects and provide valuable insights into the industry.
The worldwide drug device combination items advertise bridges the crevice between pharmaceuticals and therapeutic gadgets, advertising a special and coordinates approach to understanding care.
Market Measure and Growth
Market estimate estimations shift marginally, but the showcase is anticipated to reach an esteem of around USD 177.7 billion by 2024. Other gauges recommend a potential reach of USD 236.36 billion by 2033, reflecting a Compound Yearly Development Rate CAGR of 7.2.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleGrowth Drivers:
Enhanced Treatment Adequacy Drug device combinations can provide drugs more accurately to the target location, possibly driving to progressed treatment results. For occasion, drug eluting stents combine a stent, which opens blocked courses, with a medicine that anticipates re closure.
Improved Persistent Compliance These items can rearrange medicine regimens by coordination medicate conveyance with the gadget itself. An illustration is prefilled syringes with affront, which can move forward adherence for diabetic patients compared to multiple step vial infusions.
Rising Healthcare Costs: The potential for progressed treatment viability and pharmaceutical adherence can interpret to decreased healthcare costs within the long run by bringing down hospitalization rates and readmissions.
Challenges and Opportunities:
Regulatory Complexity: Creating and getting administrative endorsement for combination items can be challenging due to the ought to comply with controls for both drugs and gadgets.
Higher Improvement Costs The combined nature of these items can lead to expanded inquire about and improvement costs compared to conventional drugs or gadgets.
Opportunities:
Technological Headways Rising innovations like microfluidics and microneedles can lead to the improvement of more advanced and focused on drug device combinations.
Aging Populace The rising geriatric populace with unremitting conditions makes a request for user friendly and successful sedate conveyance arrangements that combination items can address.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug-Device Combination Products market. It may include historical data, market segmentation by Type (e.g., Drug-Coated Device, Prefilled Drug Delivery Systems), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug-Device Combination Products market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug-Device Combination Products market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug-Device Combination Products industry. This include advancements in Drug-Device Combination Products technology, Drug-Device Combination Products new entrants, Drug-Device Combination Products new investment, and other innovations that are shaping the future of Drug-Device Combination Products.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug-Device Combination Products market. It includes factors influencing customer ' purchasing decisions, preferences for Drug-Device Combination Products product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug-Device Combination Products market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug-Device Combination Products market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug-Device Combination Products market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug-Device Combination Products industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug-Device Combination Products market.
Market Segmentation:
Drug-Device Combination Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer and Inhaler
Transdermal Delivery System
Others
Segmentation by application
Hospital andClinic
Retail Pharmacies
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Mylan
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Drug-Device Combination Products Market Size 2019-2030
- 2.1.2 Drug-Device Combination Products Market Size CAGR by Region 2019 VS 2023 VS 2030
- 2.2 Drug-Device Combination Products Segment by Type
- 2.2.1 Drug-Coated Device
- 2.2.2 Prefilled Drug Delivery Systems
- 2.2.3 Nebulizer and Inhaler
- 2.2.4 Transdermal Delivery System
- 2.2.5 Others
- 2.3 Drug-Device Combination Products Market Size by Type
- 2.3.1 Drug-Device Combination Products Market Size CAGR by Type (2019 VS 2023 VS 2030)
- 2.3.2 Global Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
- 2.4 Drug-Device Combination Products Segment by Application
- 2.4.1 Hospital andClinic
- 2.4.2 Retail Pharmacies
- 2.4.3 Other
- 2.5 Drug-Device Combination Products Market Size by Application
- 2.5.1 Drug-Device Combination Products Market Size CAGR by Application (2019 VS 2023 VS 2030)
- 2.5.2 Global Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
- 3 Drug-Device Combination Products Market Size by Player
- 3.1 Drug-Device Combination Products Market Size Market Share by Players
- 3.1.1 Global Drug-Device Combination Products Revenue by Players (2019-2024)
- 3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2019-2024)
- 3.2 Global Drug-Device Combination Products Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Drug-Device Combination Products by Regions
- 4.1 Drug-Device Combination Products Market Size by Regions (2019-2024)
- 4.2 Americas Drug-Device Combination Products Market Size Growth (2019-2024)
- 4.3 APAC Drug-Device Combination Products Market Size Growth (2019-2024)
- 4.4 Europe Drug-Device Combination Products Market Size Growth (2019-2024)
- 4.5 Middle East & Africa Drug-Device Combination Products Market Size Growth (2019-2024)
- 5 Americas
- 5.1 Americas Drug-Device Combination Products Market Size by Country (2019-2024)
- 5.2 Americas Drug-Device Combination Products Market Size by Type (2019-2024)
- 5.3 Americas Drug-Device Combination Products Market Size by Application (2019-2024)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Drug-Device Combination Products Market Size by Region (2019-2024)
- 6.2 APAC Drug-Device Combination Products Market Size by Type (2019-2024)
- 6.3 APAC Drug-Device Combination Products Market Size by Application (2019-2024)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Drug-Device Combination Products by Country (2019-2024)
- 7.2 Europe Drug-Device Combination Products Market Size by Type (2019-2024)
- 7.3 Europe Drug-Device Combination Products Market Size by Application (2019-2024)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Drug-Device Combination Products by Region (2019-2024)
- 8.2 Middle East & Africa Drug-Device Combination Products Market Size by Type (2019-2024)
- 8.3 Middle East & Africa Drug-Device Combination Products Market Size by Application (2019-2024)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Drug-Device Combination Products Market Forecast
- 10.1 Global Drug-Device Combination Products Forecast by Regions (2025-2030)
- 10.1.1 Global Drug-Device Combination Products Forecast by Regions (2025-2030)
- 10.1.2 Americas Drug-Device Combination Products Forecast
- 10.1.3 APAC Drug-Device Combination Products Forecast
- 10.1.4 Europe Drug-Device Combination Products Forecast
- 10.1.5 Middle East & Africa Drug-Device Combination Products Forecast
- 10.2 Americas Drug-Device Combination Products Forecast by Country (2025-2030)
- 10.2.1 United States Drug-Device Combination Products Market Forecast
- 10.2.2 Canada Drug-Device Combination Products Market Forecast
- 10.2.3 Mexico Drug-Device Combination Products Market Forecast
- 10.2.4 Brazil Drug-Device Combination Products Market Forecast
- 10.3 APAC Drug-Device Combination Products Forecast by Region (2025-2030)
- 10.3.1 China Drug-Device Combination Products Market Forecast
- 10.3.2 Japan Drug-Device Combination Products Market Forecast
- 10.3.3 Korea Drug-Device Combination Products Market Forecast
- 10.3.4 Southeast Asia Drug-Device Combination Products Market Forecast
- 10.3.5 India Drug-Device Combination Products Market Forecast
- 10.3.6 Australia Drug-Device Combination Products Market Forecast
- 10.4 Europe Drug-Device Combination Products Forecast by Country (2025-2030)
- 10.4.1 Germany Drug-Device Combination Products Market Forecast
- 10.4.2 France Drug-Device Combination Products Market Forecast
- 10.4.3 UK Drug-Device Combination Products Market Forecast
- 10.4.4 Italy Drug-Device Combination Products Market Forecast
- 10.4.5 Russia Drug-Device Combination Products Market Forecast
- 10.5 Middle East & Africa Drug-Device Combination Products Forecast by Region (2025-2030)
- 10.5.1 Egypt Drug-Device Combination Products Market Forecast
- 10.5.2 South Africa Drug-Device Combination Products Market Forecast
- 10.5.3 Israel Drug-Device Combination Products Market Forecast
- 10.5.4 Turkey Drug-Device Combination Products Market Forecast
- 10.5.5 GCC Countries Drug-Device Combination Products Market Forecast
- 10.6 Global Drug-Device Combination Products Forecast by Type (2025-2030)
- 10.7 Global Drug-Device Combination Products Forecast by Application (2025-2030)
- 11 Key Players Analysis
- 11.1 GSK
- 11.1.1 GSK Company Information
- 11.1.2 GSK Drug-Device Combination Products Product Offered
- 11.1.3 GSK Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.1.4 GSK Main Business Overview
- 11.1.5 GSK Latest Developments
- 11.2 Novo Nordisk
- 11.2.1 Novo Nordisk Company Information
- 11.2.2 Novo Nordisk Drug-Device Combination Products Product Offered
- 11.2.3 Novo Nordisk Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.2.4 Novo Nordisk Main Business Overview
- 11.2.5 Novo Nordisk Latest Developments
- 11.3 Eli Lilly
- 11.3.1 Eli Lilly Company Information
- 11.3.2 Eli Lilly Drug-Device Combination Products Product Offered
- 11.3.3 Eli Lilly Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.3.4 Eli Lilly Main Business Overview
- 11.3.5 Eli Lilly Latest Developments
- 11.4 AstraZeneca
- 11.4.1 AstraZeneca Company Information
- 11.4.2 AstraZeneca Drug-Device Combination Products Product Offered
- 11.4.3 AstraZeneca Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.4.4 AstraZeneca Main Business Overview
- 11.4.5 AstraZeneca Latest Developments
- 11.5 Sanofi
- 11.5.1 Sanofi Company Information
- 11.5.2 Sanofi Drug-Device Combination Products Product Offered
- 11.5.3 Sanofi Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.5.4 Sanofi Main Business Overview
- 11.5.5 Sanofi Latest Developments
- 11.6 Boston Scientific
- 11.6.1 Boston Scientific Company Information
- 11.6.2 Boston Scientific Drug-Device Combination Products Product Offered
- 11.6.3 Boston Scientific Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.6.4 Boston Scientific Main Business Overview
- 11.6.5 Boston Scientific Latest Developments
- 11.7 Abbott
- 11.7.1 Abbott Company Information
- 11.7.2 Abbott Drug-Device Combination Products Product Offered
- 11.7.3 Abbott Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.7.4 Abbott Main Business Overview
- 11.7.5 Abbott Latest Developments
- 11.8 Boehringer Ingelheim
- 11.8.1 Boehringer Ingelheim Company Information
- 11.8.2 Boehringer Ingelheim Drug-Device Combination Products Product Offered
- 11.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.8.4 Boehringer Ingelheim Main Business Overview
- 11.8.5 Boehringer Ingelheim Latest Developments
- 11.9 Medtronic
- 11.9.1 Medtronic Company Information
- 11.9.2 Medtronic Drug-Device Combination Products Product Offered
- 11.9.3 Medtronic Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.9.4 Medtronic Main Business Overview
- 11.9.5 Medtronic Latest Developments
- 11.10 Mylan
- 11.10.1 Mylan Company Information
- 11.10.2 Mylan Drug-Device Combination Products Product Offered
- 11.10.3 Mylan Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.10.4 Mylan Main Business Overview
- 11.10.5 Mylan Latest Developments
- 11.11 3M
- 11.11.1 3M Company Information
- 11.11.2 3M Drug-Device Combination Products Product Offered
- 11.11.3 3M Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.11.4 3M Main Business Overview
- 11.11.5 3M Latest Developments
- 11.12 Hisamitsu
- 11.12.1 Hisamitsu Company Information
- 11.12.2 Hisamitsu Drug-Device Combination Products Product Offered
- 11.12.3 Hisamitsu Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.12.4 Hisamitsu Main Business Overview
- 11.12.5 Hisamitsu Latest Developments
- 11.13 Smith & Nephew
- 11.13.1 Smith & Nephew Company Information
- 11.13.2 Smith & Nephew Drug-Device Combination Products Product Offered
- 11.13.3 Smith & Nephew Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.13.4 Smith & Nephew Main Business Overview
- 11.13.5 Smith & Nephew Latest Developments
- 11.14 Molnlycke
- 11.14.1 Molnlycke Company Information
- 11.14.2 Molnlycke Drug-Device Combination Products Product Offered
- 11.14.3 Molnlycke Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.14.4 Molnlycke Main Business Overview
- 11.14.5 Molnlycke Latest Developments
- 11.15 Teleflex
- 11.15.1 Teleflex Company Information
- 11.15.2 Teleflex Drug-Device Combination Products Product Offered
- 11.15.3 Teleflex Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.15.4 Teleflex Main Business Overview
- 11.15.5 Teleflex Latest Developments
- 11.16 BD
- 11.16.1 BD Company Information
- 11.16.2 BD Drug-Device Combination Products Product Offered
- 11.16.3 BD Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.16.4 BD Main Business Overview
- 11.16.5 BD Latest Developments
- 11.17 Lepu Medical
- 11.17.1 Lepu Medical Company Information
- 11.17.2 Lepu Medical Drug-Device Combination Products Product Offered
- 11.17.3 Lepu Medical Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.17.4 Lepu Medical Main Business Overview
- 11.17.5 Lepu Medical Latest Developments
- 11.18 MicroPort
- 11.18.1 MicroPort Company Information
- 11.18.2 MicroPort Drug-Device Combination Products Product Offered
- 11.18.3 MicroPort Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.18.4 MicroPort Main Business Overview
- 11.18.5 MicroPort Latest Developments
- 11.19 Terumo
- 11.19.1 Terumo Company Information
- 11.19.2 Terumo Drug-Device Combination Products Product Offered
- 11.19.3 Terumo Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.19.4 Terumo Main Business Overview
- 11.19.5 Terumo Latest Developments
- 11.20 B. Braun
- 11.20.1 B. Braun Company Information
- 11.20.2 B. Braun Drug-Device Combination Products Product Offered
- 11.20.3 B. Braun Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.20.4 B. Braun Main Business Overview
- 11.20.5 B. Braun Latest Developments
- 11.21 Antares Pharma
- 11.21.1 Antares Pharma Company Information
- 11.21.2 Antares Pharma Drug-Device Combination Products Product Offered
- 11.21.3 Antares Pharma Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
- 11.21.4 Antares Pharma Main Business Overview
- 11.21.5 Antares Pharma Latest Developments
- 12 Research Findings and Conclusion
List of Tables
Table 1. Drug-Device Combination Products Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Drug-Coated Device
Table 3. Major Players of Prefilled Drug Delivery Systems
Table 4. Major Players of Nebulizer and Inhaler
Table 5. Major Players of Transdermal Delivery System
Table 6. Major Players of Others
Table 7. Drug-Device Combination Products Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 10. Drug-Device Combination Products Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 13. Global Drug-Device Combination Products Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Drug-Device Combination Products Revenue Market Share by Player (2019-2024)
Table 15. Drug-Device Combination Products Key Players Head office and Products Offered
Table 16. Drug-Device Combination Products Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Drug-Device Combination Products Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Drug-Device Combination Products Market Size Market Share by Regions (2019-2024)
Table 21. Global Drug-Device Combination Products Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Drug-Device Combination Products Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Drug-Device Combination Products Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Drug-Device Combination Products Market Size Market Share by Country (2019-2024)
Table 25. Americas Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 27. Americas Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 29. APAC Drug-Device Combination Products Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Drug-Device Combination Products Market Size Market Share by Region (2019-2024)
Table 31. APAC Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 33. APAC Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 35. Europe Drug-Device Combination Products Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Drug-Device Combination Products Market Size Market Share by Country (2019-2024)
Table 37. Europe Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 39. Europe Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Drug-Device Combination Products Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Drug-Device Combination Products
Table 48. Key Market Challenges & Risks of Drug-Device Combination Products
Table 49. Key Industry Trends of Drug-Device Combination Products
Table 50. Global Drug-Device Combination Products Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Drug-Device Combination Products Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Drug-Device Combination Products Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Drug-Device Combination Products Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. GSK Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 55. GSK Drug-Device Combination Products Product Offered
Table 56. GSK Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. GSK Main Business
Table 58. GSK Latest Developments
Table 59. Novo Nordisk Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 60. Novo Nordisk Drug-Device Combination Products Product Offered
Table 61. Novo Nordisk Main Business
Table 62. Novo Nordisk Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Novo Nordisk Latest Developments
Table 64. Eli Lilly Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 65. Eli Lilly Drug-Device Combination Products Product Offered
Table 66. Eli Lilly Main Business
Table 67. Eli Lilly Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Eli Lilly Latest Developments
Table 69. AstraZeneca Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 70. AstraZeneca Drug-Device Combination Products Product Offered
Table 71. AstraZeneca Main Business
Table 72. AstraZeneca Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. AstraZeneca Latest Developments
Table 74. Sanofi Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 75. Sanofi Drug-Device Combination Products Product Offered
Table 76. Sanofi Main Business
Table 77. Sanofi Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Sanofi Latest Developments
Table 79. Boston Scientific Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 80. Boston Scientific Drug-Device Combination Products Product Offered
Table 81. Boston Scientific Main Business
Table 82. Boston Scientific Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Boston Scientific Latest Developments
Table 84. Abbott Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 85. Abbott Drug-Device Combination Products Product Offered
Table 86. Abbott Main Business
Table 87. Abbott Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Abbott Latest Developments
Table 89. Boehringer Ingelheim Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 90. Boehringer Ingelheim Drug-Device Combination Products Product Offered
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Medtronic Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 95. Medtronic Drug-Device Combination Products Product Offered
Table 96. Medtronic Main Business
Table 97. Medtronic Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Medtronic Latest Developments
Table 99. Mylan Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 100. Mylan Drug-Device Combination Products Product Offered
Table 101. Mylan Main Business
Table 102. Mylan Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Mylan Latest Developments
Table 104. 3M Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 105. 3M Drug-Device Combination Products Product Offered
Table 106. 3M Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. 3M Main Business
Table 108. 3M Latest Developments
Table 109. Hisamitsu Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 110. Hisamitsu Drug-Device Combination Products Product Offered
Table 111. Hisamitsu Main Business
Table 112. Hisamitsu Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Hisamitsu Latest Developments
Table 114. Smith & Nephew Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 115. Smith & Nephew Drug-Device Combination Products Product Offered
Table 116. Smith & Nephew Main Business
Table 117. Smith & Nephew Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Smith & Nephew Latest Developments
Table 119. Molnlycke Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 120. Molnlycke Drug-Device Combination Products Product Offered
Table 121. Molnlycke Main Business
Table 122. Molnlycke Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Molnlycke Latest Developments
Table 124. Teleflex Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 125. Teleflex Drug-Device Combination Products Product Offered
Table 126. Teleflex Main Business
Table 127. Teleflex Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Teleflex Latest Developments
Table 129. BD Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 130. BD Drug-Device Combination Products Product Offered
Table 131. BD Main Business
Table 132. BD Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. BD Latest Developments
Table 134. Lepu Medical Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 135. Lepu Medical Drug-Device Combination Products Product Offered
Table 136. Lepu Medical Main Business
Table 137. Lepu Medical Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Lepu Medical Latest Developments
Table 139. MicroPort Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 140. MicroPort Drug-Device Combination Products Product Offered
Table 141. MicroPort Main Business
Table 142. MicroPort Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. MicroPort Latest Developments
Table 144. Terumo Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 145. Terumo Drug-Device Combination Products Product Offered
Table 146. Terumo Main Business
Table 147. Terumo Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Terumo Latest Developments
Table 149. B. Braun Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 150. B. Braun Drug-Device Combination Products Product Offered
Table 151. B. Braun Main Business
Table 152. B. Braun Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. B. Braun Latest Developments
Table 154. Antares Pharma Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 155. Antares Pharma Drug-Device Combination Products Product Offered
Table 156. Antares Pharma Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 157. Antares Pharma Main Business
Table 158. Antares Pharma Latest Developments
Table 1. Drug-Device Combination Products Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Drug-Coated Device
Table 3. Major Players of Prefilled Drug Delivery Systems
Table 4. Major Players of Nebulizer and Inhaler
Table 5. Major Players of Transdermal Delivery System
Table 6. Major Players of Others
Table 7. Drug-Device Combination Products Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 10. Drug-Device Combination Products Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 13. Global Drug-Device Combination Products Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Drug-Device Combination Products Revenue Market Share by Player (2019-2024)
Table 15. Drug-Device Combination Products Key Players Head office and Products Offered
Table 16. Drug-Device Combination Products Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Drug-Device Combination Products Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Drug-Device Combination Products Market Size Market Share by Regions (2019-2024)
Table 21. Global Drug-Device Combination Products Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Drug-Device Combination Products Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Drug-Device Combination Products Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Drug-Device Combination Products Market Size Market Share by Country (2019-2024)
Table 25. Americas Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 27. Americas Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 29. APAC Drug-Device Combination Products Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Drug-Device Combination Products Market Size Market Share by Region (2019-2024)
Table 31. APAC Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 33. APAC Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 35. Europe Drug-Device Combination Products Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Drug-Device Combination Products Market Size Market Share by Country (2019-2024)
Table 37. Europe Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 39. Europe Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Drug-Device Combination Products Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Drug-Device Combination Products Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Drug-Device Combination Products Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Drug-Device Combination Products
Table 48. Key Market Challenges & Risks of Drug-Device Combination Products
Table 49. Key Industry Trends of Drug-Device Combination Products
Table 50. Global Drug-Device Combination Products Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Drug-Device Combination Products Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Drug-Device Combination Products Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Drug-Device Combination Products Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. GSK Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 55. GSK Drug-Device Combination Products Product Offered
Table 56. GSK Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. GSK Main Business
Table 58. GSK Latest Developments
Table 59. Novo Nordisk Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 60. Novo Nordisk Drug-Device Combination Products Product Offered
Table 61. Novo Nordisk Main Business
Table 62. Novo Nordisk Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Novo Nordisk Latest Developments
Table 64. Eli Lilly Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 65. Eli Lilly Drug-Device Combination Products Product Offered
Table 66. Eli Lilly Main Business
Table 67. Eli Lilly Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Eli Lilly Latest Developments
Table 69. AstraZeneca Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 70. AstraZeneca Drug-Device Combination Products Product Offered
Table 71. AstraZeneca Main Business
Table 72. AstraZeneca Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. AstraZeneca Latest Developments
Table 74. Sanofi Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 75. Sanofi Drug-Device Combination Products Product Offered
Table 76. Sanofi Main Business
Table 77. Sanofi Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Sanofi Latest Developments
Table 79. Boston Scientific Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 80. Boston Scientific Drug-Device Combination Products Product Offered
Table 81. Boston Scientific Main Business
Table 82. Boston Scientific Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Boston Scientific Latest Developments
Table 84. Abbott Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 85. Abbott Drug-Device Combination Products Product Offered
Table 86. Abbott Main Business
Table 87. Abbott Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Abbott Latest Developments
Table 89. Boehringer Ingelheim Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 90. Boehringer Ingelheim Drug-Device Combination Products Product Offered
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Medtronic Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 95. Medtronic Drug-Device Combination Products Product Offered
Table 96. Medtronic Main Business
Table 97. Medtronic Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Medtronic Latest Developments
Table 99. Mylan Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 100. Mylan Drug-Device Combination Products Product Offered
Table 101. Mylan Main Business
Table 102. Mylan Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Mylan Latest Developments
Table 104. 3M Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 105. 3M Drug-Device Combination Products Product Offered
Table 106. 3M Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. 3M Main Business
Table 108. 3M Latest Developments
Table 109. Hisamitsu Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 110. Hisamitsu Drug-Device Combination Products Product Offered
Table 111. Hisamitsu Main Business
Table 112. Hisamitsu Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Hisamitsu Latest Developments
Table 114. Smith & Nephew Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 115. Smith & Nephew Drug-Device Combination Products Product Offered
Table 116. Smith & Nephew Main Business
Table 117. Smith & Nephew Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Smith & Nephew Latest Developments
Table 119. Molnlycke Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 120. Molnlycke Drug-Device Combination Products Product Offered
Table 121. Molnlycke Main Business
Table 122. Molnlycke Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Molnlycke Latest Developments
Table 124. Teleflex Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 125. Teleflex Drug-Device Combination Products Product Offered
Table 126. Teleflex Main Business
Table 127. Teleflex Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Teleflex Latest Developments
Table 129. BD Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 130. BD Drug-Device Combination Products Product Offered
Table 131. BD Main Business
Table 132. BD Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. BD Latest Developments
Table 134. Lepu Medical Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 135. Lepu Medical Drug-Device Combination Products Product Offered
Table 136. Lepu Medical Main Business
Table 137. Lepu Medical Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Lepu Medical Latest Developments
Table 139. MicroPort Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 140. MicroPort Drug-Device Combination Products Product Offered
Table 141. MicroPort Main Business
Table 142. MicroPort Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. MicroPort Latest Developments
Table 144. Terumo Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 145. Terumo Drug-Device Combination Products Product Offered
Table 146. Terumo Main Business
Table 147. Terumo Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Terumo Latest Developments
Table 149. B. Braun Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 150. B. Braun Drug-Device Combination Products Product Offered
Table 151. B. Braun Main Business
Table 152. B. Braun Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. B. Braun Latest Developments
Table 154. Antares Pharma Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 155. Antares Pharma Drug-Device Combination Products Product Offered
Table 156. Antares Pharma Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 157. Antares Pharma Main Business
Table 158. Antares Pharma Latest Developments
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization1.png "Anupriya Singh")
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (26 January, 2025)
- Notify To Team (26 January, 2025)
- Report updation (27 January, 2025)
- Report Quality Check (27 January, 2025)
- Report Dispatch (28 January, 2025)
- Hard Copy
Recently Viewed Products
Global Drug-Device Combination Products Market Growth (Status and Outlook) 2024-2030
We are friendly and approachable, give us a call.